Global Extracorporeal CO2 Removal Devices Market by End Use (Clinics, ASCs), by Application (ARDS, COPD), by Access (Arteriovenous, Venovenous) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Summary of the Report
Global extracorporeal CO2 removal device market was valued at USD 81.1 million in 2020. It is expected to grow at 5.3% compound annual growth rate (CAGR), between 2021 and 2028. New products have been developed to improve blood flow and gas exchange. Several extracorporeal removal devices were approved by regulators during the COVID-19 pandemic. This helped market players increase their product sales. Alung Technologies was granted an Emergency Use Authorization (EUA), by the U.S. FDA, for its Hemolung Respiratory Assist System, (RAS) to treat COVID-19.
COVID-19, a novel coronavirus (SARSCoV-2) that has recently been identified as a major global problem, has caused thousands of deaths and is now a severe epidemic. This disease's main feature was its respiratory manifestation. About 15-20% of patients with confirmed or suspected cases required mechanical ventilation. Since the invention of COVID-19, extracorporeal CO2 removal equipment has been more popular. During the peak period, however, the number and availability of ECMO machines was not sufficient.
The market for these devices is expected to grow significantly due to the increasing demand. Many technological advancements and strategies in recent years have allowed extracorporeal CO2 removal systems to be simplified and smaller. Extracorporeal CO2 removal devices have become more accessible and easier to use thanks to a variety of technical advancements. Market growth is expected to be boosted by technological advances.
These devices can be used for patients suffering from severe COPD exacerbation or to establish ultraprotective or protective measures in patients with ARDS. These devices remove blood and combat the harmful effects of hypercapnia. The WHO estimates that COPD is the third leading cause for death worldwide and was responsible for 3.23 million deaths in 2019. According to the America Lung Association (ALA), more than 11,000,000 people are diagnosed with COPD each year in the U.S. According to the America Lung Association, increasing COPD cases will increase product adoption and thus boost market growth.
Product Insights
In 2020, extracorporeal CO2 machine segment was responsible for 52.3% of the total revenue. The development and potential applications for extracorporeal CO2 extraction machines has been simplified to a great extent, avoiding many of the initial issues associated with ECMO. Extracorporeal CO2 extraction devices are theoretically simpler, require less personnel and logistic requirements, which leads to a higher preference from patients. ECCO2R's increasing market share is expected to result in greater benefits.
Over the forecast period, disposables will grow at a substantial CAGR of 4.87%. Extracorporeal CO2 removal therapy uses disposables per patient basis. This segment is expected to grow because of the high demand and consumption for consumables. The forecast period will see an increase in disposables needed for various COPD- and ARDS procedures. This is expected to boost the demand for extracorporeal CO2 removal equipment.
Access Insights
In 2020, 64.30% of the revenue came from the venovenous segment. Venovenous access involves the extraction of blood from the central vein using a drainage cannula and a centrifugal pump to create flow across the gas exchange membrane. A new generation of extracorporeal CO2 extraction devices has been created in recent years. The new generation of efficient venovenous extracorporeal carbon dioxide removal devices has replaced the arterio-venous procedure. They do not require arterial puncture. This will lead to a rapid growth in the segment.
According to forecasts, the arteriovenous segment will experience the highest CAGR. The blood flows through the arteriovenous extracorporeal carbon dioxide removal devices and into the contralateral vein. The arteriovenous system is a simplified, high-tech membrane lung that features high gas transfer efficiency, low resistance to blood flow and no heat exchanger. The above factors will likely accelerate segment growth.
End-use Insights
In 2020, hospitals accounted for the largest revenue share at over 46.36%. The segment is expected to grow due to an increase in hospital admissions, particularly for patients with ARDS, which has been exacerbated by the recent COVID-19 outbreak.
From 2021 to 2028, the segment Ambulatory Surgical Centers will experience a significant CAGR. This is due to rising incidences of acute respiratory failure in rural areas with limited access to healthcare services. ASCs are more accessible to patients, have lower out-of pocket costs and offer lower facility costs. A high preference for ASCs will fuel segment growth.
Application Insights
In 2020, the bridge to lung transplant segment was responsible for more than 40% of all revenue. Extracorporeal CO2 removal devices can be used to bridge patients awaiting lung transplantation who develop life-threatening hypercarbia. Market growth is expected to be accelerated by the increasing focus of manufacturers such as Alung Technologies or Xenios AG on extracorporeal CO2 removal systems for lung transplantation bridge.
These devices are very popular among patients suffering from ARDS. They can remove CO2 and enable lung-protective ventilation by reducing plateau pressures and tidal volume. These devices are useful in managing ARDS. They allow for more protection and ventilation, while avoiding extreme levels of respiratory acidosis.
Regional Insights
Asia Pacific will experience the fastest CAGR at 7.24% over the forecast period. Regional market growth is expected to be accelerated by the presence of large patient pools, increased awareness about acute respiratory failure, and increasing government healthcare spending in developing countries like India and Japan. Market growth is encouraged by supportive government initiatives and the high success rate of extracorporeal CO2 extraction devices during respiratory surgery.
There is a large population with low per-capita incomes in the region, which means that there is a high demand for affordable treatment options. Multinational companies are eager to invest in developing countries like China and anticipate regional market growth. The North American regional market will grow if there is improved healthcare infrastructure and increased product adoption, particularly during the COVID-19 pandemic.
Regional market growth will be accelerated by the adoption of new technologies early and a large patient base for ARDS/COPD. Extracorporeal CO2 removal devices will also be in demand due to the rising incidence of chronic respiratory disease. Market growth has been accelerated by the growing preference for minimally invasive and safe ventilation devices.
Europe's market is forecast to grow at the second fastest CAGR of more than 6% over the forecast period. The market is expected to grow due to rising demand for healthcare devices and the increasing prevalence of chronic diseases such as respiratory failure. The market is also being boosted by favorable reimbursement policies, increased government investments in long term healthcare and a growing healthcare research infrastructure.
Market Share Insights & Key Companies
Companies use a variety of strategies to keep their market share. These include product approvals, new product launches, acquisitions and partnerships, as well as product approvals. Alung Technologies, for example, announced in May 2020 that it had launched the commercialization of the next-generation artificial lungs. Extracorporeal CO2 removal devices manufactured by Hemolung Respiratory Assist System are specifically designed for this therapy. The following are some of the major players in the extracorporeal CO2 Removal Devices market:
-
Medtronic
-
Getinge AB
-
Xenios AG
-
Alung Technologies
-
ESTOR SpA
-
Medica SpA
-
Aferectica Srl
Up Market Research published a new report titled “Extracorporeal CO2 Removal Devices Market research report which is segmented by End Use (Clinics, ASCs), by Application (ARDS, COPD), by Access (Arteriovenous, Venovenous), By Players/Companies ESTOR SPA, Medtronic, Medica Spa and Aferectica Srl, Alung Technologies, Xenos AG, Getinge AB”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
Report Attributes | Report Details |
Report Title | Extracorporeal CO2 Removal Devices Market Research Report |
By End Use | Clinics, ASCs |
By Application | ARDS, COPD |
By Access | Arteriovenous, Venovenous |
By Companies | ESTOR SPA, Medtronic, Medica Spa and Aferectica Srl, Alung Technologies, Xenos AG, Getinge AB |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 232 |
Number of Tables & Figures | 163 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Extracorporeal CO2 Removal Devices Market Report Segments:
The market is segmented by End Use (Clinics, ASCs), by Application (ARDS, COPD), by Access (Arteriovenous, Venovenous).
Extracorporeal CO2 Removal Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Extracorporeal CO2 Removal Devices Market
Overview of the regional outlook of the Extracorporeal CO2 Removal Devices Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Extracorporeal CO2 Removal Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Extracorporeal CO2 Removal Devices Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Clinics
2. ASCs
7. By Application:1. ARDS
2. COPD
8. By Access:1. Arteriovenous
2. Venovenous
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Extracorporeal CO2 Removal Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Extracorporeal CO2 Removal Devices Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Extracorporeal CO2 Removal Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Extracorporeal CO2 Removal Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Extracorporeal CO2 Removal Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Extracorporeal CO2 Removal Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Extracorporeal CO2 Removal Devices Market Size & Forecast, 2018-2028
4.5.1 Extracorporeal CO2 Removal Devices Market Size and Y-o-Y Growth
4.5.2 Extracorporeal CO2 Removal Devices Market Absolute $ Opportunity
Chapter 5 Global Extracorporeal CO2 Removal Devices Market Analysis and Forecast by End Use
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End Use
5.1.2 Basis Point Share (BPS) Analysis by End Use
5.1.3 Absolute $ Opportunity Assessment by End Use
5.2 Extracorporeal CO2 Removal Devices Market Size Forecast by End Use
5.2.1 Clinics
5.2.2 ASCs
5.3 Market Attractiveness Analysis by End Use
Chapter 6 Global Extracorporeal CO2 Removal Devices Market Analysis and Forecast by Application
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Application
6.1.2 Basis Point Share (BPS) Analysis by Application
6.1.3 Absolute $ Opportunity Assessment by Application
6.2 Extracorporeal CO2 Removal Devices Market Size Forecast by Application
6.2.1 ARDS
6.2.2 COPD
6.3 Market Attractiveness Analysis by Application
Chapter 7 Global Extracorporeal CO2 Removal Devices Market Analysis and Forecast by Access
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Access
7.1.2 Basis Point Share (BPS) Analysis by Access
7.1.3 Absolute $ Opportunity Assessment by Access
7.2 Extracorporeal CO2 Removal Devices Market Size Forecast by Access
7.2.1 Arteriovenous
7.2.2 Venovenous
7.3 Market Attractiveness Analysis by Access
Chapter 8 Global Extracorporeal CO2 Removal Devices Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Extracorporeal CO2 Removal Devices Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Extracorporeal CO2 Removal Devices Analysis and Forecast
10.1 Introduction
10.2 North America Extracorporeal CO2 Removal Devices Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Extracorporeal CO2 Removal Devices Market Size Forecast by End Use
10.6.1 Clinics
10.6.2 ASCs
10.7 Basis Point Share (BPS) Analysis by End Use
10.8 Absolute $ Opportunity Assessment by End Use
10.9 Market Attractiveness Analysis by End Use
10.10 North America Extracorporeal CO2 Removal Devices Market Size Forecast by Application
10.10.1 ARDS
10.10.2 COPD
10.11 Basis Point Share (BPS) Analysis by Application
10.12 Absolute $ Opportunity Assessment by Application
10.13 Market Attractiveness Analysis by Application
10.14 North America Extracorporeal CO2 Removal Devices Market Size Forecast by Access
10.14.1 Arteriovenous
10.14.2 Venovenous
10.15 Basis Point Share (BPS) Analysis by Access
10.16 Absolute $ Opportunity Assessment by Access
10.17 Market Attractiveness Analysis by Access
Chapter 11 Europe Extracorporeal CO2 Removal Devices Analysis and Forecast
11.1 Introduction
11.2 Europe Extracorporeal CO2 Removal Devices Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Extracorporeal CO2 Removal Devices Market Size Forecast by End Use
11.6.1 Clinics
11.6.2 ASCs
11.7 Basis Point Share (BPS) Analysis by End Use
11.8 Absolute $ Opportunity Assessment by End Use
11.9 Market Attractiveness Analysis by End Use
11.10 Europe Extracorporeal CO2 Removal Devices Market Size Forecast by Application
11.10.1 ARDS
11.10.2 COPD
11.11 Basis Point Share (BPS) Analysis by Application
11.12 Absolute $ Opportunity Assessment by Application
11.13 Market Attractiveness Analysis by Application
11.14 Europe Extracorporeal CO2 Removal Devices Market Size Forecast by Access
11.14.1 Arteriovenous
11.14.2 Venovenous
11.15 Basis Point Share (BPS) Analysis by Access
11.16 Absolute $ Opportunity Assessment by Access
11.17 Market Attractiveness Analysis by Access
Chapter 12 Asia Pacific Extracorporeal CO2 Removal Devices Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Extracorporeal CO2 Removal Devices Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Extracorporeal CO2 Removal Devices Market Size Forecast by End Use
12.6.1 Clinics
12.6.2 ASCs
12.7 Basis Point Share (BPS) Analysis by End Use
12.8 Absolute $ Opportunity Assessment by End Use
12.9 Market Attractiveness Analysis by End Use
12.10 Asia Pacific Extracorporeal CO2 Removal Devices Market Size Forecast by Application
12.10.1 ARDS
12.10.2 COPD
12.11 Basis Point Share (BPS) Analysis by Application
12.12 Absolute $ Opportunity Assessment by Application
12.13 Market Attractiveness Analysis by Application
12.14 Asia Pacific Extracorporeal CO2 Removal Devices Market Size Forecast by Access
12.14.1 Arteriovenous
12.14.2 Venovenous
12.15 Basis Point Share (BPS) Analysis by Access
12.16 Absolute $ Opportunity Assessment by Access
12.17 Market Attractiveness Analysis by Access
Chapter 13 Latin America Extracorporeal CO2 Removal Devices Analysis and Forecast
13.1 Introduction
13.2 Latin America Extracorporeal CO2 Removal Devices Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Extracorporeal CO2 Removal Devices Market Size Forecast by End Use
13.6.1 Clinics
13.6.2 ASCs
13.7 Basis Point Share (BPS) Analysis by End Use
13.8 Absolute $ Opportunity Assessment by End Use
13.9 Market Attractiveness Analysis by End Use
13.10 Latin America Extracorporeal CO2 Removal Devices Market Size Forecast by Application
13.10.1 ARDS
13.10.2 COPD
13.11 Basis Point Share (BPS) Analysis by Application
13.12 Absolute $ Opportunity Assessment by Application
13.13 Market Attractiveness Analysis by Application
13.14 Latin America Extracorporeal CO2 Removal Devices Market Size Forecast by Access
13.14.1 Arteriovenous
13.14.2 Venovenous
13.15 Basis Point Share (BPS) Analysis by Access
13.16 Absolute $ Opportunity Assessment by Access
13.17 Market Attractiveness Analysis by Access
Chapter 14 Middle East & Africa (MEA) Extracorporeal CO2 Removal Devices Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Extracorporeal CO2 Removal Devices Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Extracorporeal CO2 Removal Devices Market Size Forecast by End Use
14.6.1 Clinics
14.6.2 ASCs
14.7 Basis Point Share (BPS) Analysis by End Use
14.8 Absolute $ Opportunity Assessment by End Use
14.9 Market Attractiveness Analysis by End Use
14.10 Middle East & Africa (MEA) Extracorporeal CO2 Removal Devices Market Size Forecast by Application
14.10.1 ARDS
14.10.2 COPD
14.11 Basis Point Share (BPS) Analysis by Application
14.12 Absolute $ Opportunity Assessment by Application
14.13 Market Attractiveness Analysis by Application
14.14 Middle East & Africa (MEA) Extracorporeal CO2 Removal Devices Market Size Forecast by Access
14.14.1 Arteriovenous
14.14.2 Venovenous
14.15 Basis Point Share (BPS) Analysis by Access
14.16 Absolute $ Opportunity Assessment by Access
14.17 Market Attractiveness Analysis by Access
Chapter 15 Competition Landscape
15.1 Extracorporeal CO2 Removal Devices Market: Competitive Dashboard
15.2 Global Extracorporeal CO2 Removal Devices Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 ESTOR SPA
15.3.2 Medtronic
15.3.3 Medica Spa and Aferectica Srl
15.3.4 Alung Technologies
15.3.5 Xenos AG
15.3.6 Getinge AB